Fayez Sarofim & CO Pfizer Inc Transaction History

Fayez Sarofim & CO

$38.7 Billion
Q3 2024

A detailed history of Fayez Sarofim & CO transactions in Pfizer Inc stock. As of the latest transaction made, Fayez Sarofim & CO holds 277,651 shares of PFE stock, worth $7.42 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

277,651

Previous 432,131 35.75%

Holding current value

$7.42 Million

Previous $12.1 Million 33.55%

% of portfolio

0.02%

Previous 0.03%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$27.7 - $31.39 $4.28 Million - $4.85 Million	-154,480 Reduced 35.75%	277,651 $8.04 Million
Q2 2024 Aug 14, 2024	SELL	$25.26 - $29.6 $1.87 Million - $2.19 Million	-73,848 Reduced 14.6%	432,131 $12.1 Million
Q1 2024 May 14, 2024	SELL	$25.89 - $29.73 $5.04 Million - $5.79 Million	-194,741 Reduced 27.79%	505,979 $14 Million
Q4 2023 Feb 14, 2024	SELL	$26.13 - $33.94 $1.06 Million - $1.38 Million	-40,611 Reduced 5.48%	700,720 $20.2 Million
Q3 2023 Nov 14, 2023	SELL	$32.09 - $37.51 $650,592 - $760,477	-20,274 Reduced 2.66%	741,331 $24.6 Million
Q2 2023 Aug 14, 2023	SELL	$36.12 - $41.79 $2.5 Million - $2.89 Million	-69,125 Reduced 8.32%	761,605 $27.9 Million
Q1 2023 May 11, 2023	BUY	$39.39 - $51.28 $720,640 - $938,167	18,295 Added 2.25%	830,730 $33.9 Million
Q4 2022 Feb 13, 2023	SELL	$41.75 - $54.5 $1.55 Million - $2.02 Million	-37,043 Reduced 4.36%	812,435 $41.6 Million
Q3 2022 Nov 14, 2022	BUY	$43.76 - $53.42 $1.74 Million - $2.12 Million	39,657 Added 4.9%	849,478 $37.2 Million
Q2 2022 Aug 12, 2022	BUY	$46.53 - $55.17 $327,105 - $387,845	7,030 Added 0.88%	809,821 $42.5 Million
Q1 2022 May 16, 2022	BUY	$45.75 - $56.69 $1.16 Million - $1.44 Million	25,334 Added 3.26%	802,791 $41.6 Million
Q4 2021 Feb 11, 2022	BUY	$41.32 - $61.25 $1.48 Million - $2.19 Million	35,825 Added 4.83%	777,457 $45.9 Million
Q3 2021 Nov 15, 2021	SELL	$39.25 - $50.42 $318,317 - $408,906	-8,110 Reduced 1.08%	741,632 $31.9 Million
Q2 2021 Aug 13, 2021	BUY	$35.91 - $40.68 $1.65 Million - $1.87 Million	45,888 Added 6.52%	749,742 $29.4 Million
Q1 2021 May 13, 2021	SELL	$33.49 - $37.77 $728,541 - $821,648	-21,754 Reduced 3.0%	703,854 $25.5 Million
Q4 2020 Feb 11, 2021	BUY	$33.47 - $42.56 $140,741 - $178,964	4,205 Added 0.58%	725,608 $26.7 Million
Q3 2020 Nov 13, 2020	BUY	$31.75 - $37.25 $304,895 - $357,711	9,603 Added 1.35%	721,403 $26.5 Million
Q2 2020 Aug 11, 2020	BUY	$30.12 - $36.54 $1.02 Million - $1.24 Million	33,908 Added 5.0%	711,800 $23.3 Million
Q1 2020 May 12, 2020	SELL	$27.03 - $38.62 $75,467 - $107,827	-2,792 Reduced 0.41%	677,892 $22.1 Million
Q4 2019 Feb 14, 2020	BUY	$32.92 - $37.36 $211,445 - $239,963	6,423 Added 0.95%	680,684 $26.7 Million
Q3 2019 Nov 13, 2019	BUY	$32.49 - $42.13 $63,063 - $81,774	1,941 Added 0.29%	674,261 $24.2 Million
Q2 2019 Aug 09, 2019	SELL	$36.98 - $41.52 $4.26 Million - $4.78 Million	-115,125 Reduced 14.62%	672,320 $29.1 Million
Q1 2019 May 14, 2019	BUY	$37.5 - $41.2 $4.45 Million - $4.89 Million	118,622 Added 17.74%	787,445 $33.4 Million
Q4 2018 Feb 13, 2019	BUY	$38.47 - $43.86 $27,890 - $31,798	725 Added 0.11%	668,823 $29.2 Million
Q3 2018 Nov 14, 2018	SELL	$34.47 - $41.81 $93,586 - $113,514	-2,715 Reduced 0.4%	668,098 $29.4 Million
Q2 2018 Aug 14, 2018	SELL	$32.98 - $35.16 $288,970 - $308,071	-8,762 Reduced 1.29%	670,813 $24.3 Million
Q1 2018 May 10, 2018	SELL	$31.91 - $37.02 $39,153 - $45,423	-1,227 Reduced 0.18%	679,575 $24.1 Million
Q4 2017 Feb 13, 2018	SELL	$33.26 - $35.29 $24,911 - $26,432	-749 Reduced 0.11%	680,802 $24.7 Million
Q3 2017 Nov 08, 2017	BUY	$31.0 - $34.15 $21.1 Million - $23.3 Million	681,551	681,551 $24.3 Million

Others Institutions Holding PFE

# of Institutions

3,260

Shares Held

3.61B

Call Options Held

77.2M

Put Options Held

122M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $150B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fayez Sarofim & CO, based on Form 13F filings with the SEC.

News

Stay updated on Fayez Sarofim & CO with notifications on news.

Account